Thiadiazole derivatives as New Class of β-glucuronidase inhibitors

被引：27
作者：
Salar, Uzma [1 ]
Taha, Muhammad [2 ,3 ]
Ismail, Nor Hadiani [2 ]
Khan, Khalid Mohammed [1 ]
Imran, Syahrul [2 ]
Perveen, Shahnaz [4 ]
Wadood, Abdul [5 ]
Riaz, Muhammad [5 ]
机构：
[1] Univ Karachi, Int Ctr Chem & Biol Sci, HEJ Res Inst Chem, Karachi 75270, Pakistan
[2] Univ Teknol MARA UiTM, Atta Ur Rahman Inst Nat Prod Discovery, Puncak Alam Campus, Bandar Puncak Alam 42300, Selangor, Malaysia
[3] Univ Teknol MARA, Fac Sci Appl, Shah Alam 40450, Selangor, Malaysia
[4] PCSIR Labs Complex, Karachi 75280, Pakistan
[5] Abdul Wali Khan Univ Mardan, UCSS, Computat Med Chem Lab, Dept Biochem, Mardan, Pakistan
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2016年 / 24卷 / 08期
关键词：
Synthesis; Thiadiazole; beta-Glucuronidase; In vitro; Molecular docking; Structure-activity relationship; 1,3,4-THIADIAZOLE; DEFICIENCY; DOCKING; CANCER; SITE;
D O I：
10.1016/j.bmc.2016.03.020
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Thiadiazole derivatives 1-24 were synthesized via a single step reaction and screened for in vitro beta-glucuronidase inhibitory activity. All the synthetic compounds displayed good inhibitory activity in the range of IC50 = 2.16 +/- 0.01-58.06 +/- 1.60 mu M as compare to standard D-saccharic acid 1,4-lactone (IC50 = 48.4 +/- 1.25 mu M). Molecular docking study was conducted in order to establish the structure-activity relationship (SAR) which demonstrated that thiadiazole as well as both aryl moieties (aryl and N-aryl) involved to exhibit the inhibitory potential. All the synthetic compounds were characterized by spectroscopic techniques H-1, C-13 NMR, and EIMS. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码：1909 / 1918
页数：10
相关论文
共 51 条
[1]  
Ali KA, 2011, ACTA POL PHARM, V68, P237
[2]   URINARY BETA-GLUCURONIDASE ACTIVITY IN PATIENTS WITH URINARY-TRACT INFECTION [J].
BANK, N ;
BAILINE, SH .
NEW ENGLAND JOURNAL OF MEDICINE, 1965, 272 (02) :70-&
[3]   ENZYME ACTIVITY IN RELATION TO CANCER - THE URINARY BETA-GLUCURONIDASE ACTIVITY OF PATIENTS SUFFERING FROM MALIGNANT DISEASE [J].
BOYLAND, E ;
GASSON, JE ;
WILLIAMS, DC .
BRITISH JOURNAL OF CANCER, 1957, 11 (01) :120-129
[4]   Synthesis of thiadiazole derivatives bearing hydrazone moieties and evaluation of their pharmacological effects on anxiety, depression, and nociception parameters in mice [J].
Can, Ozgur Devrim ;
Altintop, Mehlika Dilek ;
Ozkay, Umide Demir ;
Ucel, Umut Irfan ;
Dogruer, Burge ;
Kaplancikli, Zafer Asim .
ARCHIVES OF PHARMACAL RESEARCH, 2012, 35 (04) :659-669
[5]   Synthesis and Antiviral Activity of 5-(4-Chlorophenyl)-1,3,4-Thiadiazole Sulfonamides [J].
Chen, Zhuo ;
Xu, Weiming ;
Liu, Keming ;
Yang, Song ;
Fan, Huitao ;
Bhadury, Pinaki S. ;
Hu, De-Yu ;
Zhang, Yuping .
MOLECULES, 2010, 15 (12) :9046-9056
[6]   Synthesis of 2-amino-5-sulfanyl-1,3,4-thiadiazole derivatives and evaluation of their antidepressant and anxiolytic activity [J].
Clerici, F ;
Pocar, D ;
Guido, M ;
Loche, A ;
Perlini, V ;
Brufani, M .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (06) :931-936
[7]   Synthesis of some new pyrazole-based 1,3-thiazoles and 1,3,4-thiadiazoles as anticancer agents [J].
Dawood, Kamal M. ;
Eldebss, Taha M. A. ;
El-Zahabi, Heba S. A. ;
Yousef, Mahmoud H. ;
Metz, Peter .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 70 :740-749
[8]   Antituberculosis agents X.: Synthesis and evaluation of in vitro antituberculosis activity of 2-(5-nitro-2-furyl)- and 2-(1-methyl5-nitro-1H-imidazol-2-yl)-1,3,4-thiadiazole derivatives [J].
Foroumadi, A ;
Soltani, F ;
Jabini, R ;
Moshafi, MH ;
Rasnani, FM .
ARCHIVES OF PHARMACAL RESEARCH, 2004, 27 (05) :502-506
[9]   URINARY BETA-GLUCURONIDASE ACTIVITY IN RENAL-DISEASE [J].
GONICK, HC ;
KRAMER, HJ ;
SCHAPIRO, AE .
ARCHIVES OF INTERNAL MEDICINE, 1973, 132 (01) :63-69
[10]   BETA-GLUCURONIDASE DEFICIENCY MUCOPOLYSACCHARIDOSIS - STUDIES IN CULTURED FIBROBLASTS [J].
HALL, CW ;
CANTZ, M ;
NEUFELD, EF .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1973, 155 (01) :32-38
123456